...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis
【24h】

Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis

机译:伊曲康唑通过聚合物胶束的零级递送并入原位眼用凝胶治疗真菌性角膜炎

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this article is to investigate the role of amphiphilic block copolymer-based polymeric micelles of itraconazole for the management of fungal keratitis to overcome the limitations of the conventional dosage form. The polymeric micelles were made using pluronics above critical micelle concentration. Itraconazole-loaded polymeric micelles prepared by rotary evaporation method were characterized and the optimized micellar formulation (M5) was selected on the basis of least micelle size (79.99 nm), maximum entrapment efficiency (91.32% +/- 1.73%) and in vitro permeation (90.28% +/- 0.31%) in 8 h, that best fitted zero-order kinetics. M5 was developed as pH sensitive in situ gel and characterized for various parameters. The optimized in situ gel (F5) proved to be superior in its ex vivo transcorneal permeation when compared with Itral (R) eye drop and pure drug suspension, exhibiting 41.45% +/- 0.87% permeation with zero-order kinetics (r(2) = 0.994) across goat cornea. Transmission electron microscopy revealed spherical polymeric micelles entrapped in the gel matrix. A spectrum of tests revealed hydration capability, non-irritancy, and histologically safe gel formulation that had appropriate handling characteristics. Conclusively, a controlled release pH-sensitive ocular formulation capable of carrying drug to the anterior segment of the eye via topical delivery was successfully developed for the treatment of fungal keratitis. (C) 2015 Published by Elsevier B.V.
机译:本文的目的是研究基于两亲嵌段共聚物的伊曲康唑聚合胶束在克服真菌性角膜炎方面的作用,以克服常规剂型的局限性。使用高于临界胶束浓度的普卢尼克斯(Pluronics)制备聚合物胶束。表征了通过旋转蒸发法制备的载有伊曲康唑的聚合物胶束,并根据最小胶束尺寸(79.99 nm),最大包封率(91.32%+/- 1.73%)和体外渗透率选择了最佳的胶束配方(M5) (90.28%+/- 0.31%)在8小时内,最适合零级动力学。 M5被开发为对pH敏感的原位凝胶,并针对各种参数进行了表征。经优化的原位凝胶(F5)与Itral(R)眼药水和纯药物悬液相比在离体透角膜渗透性方面表现优异,在零级动力学下表现出41.45%+/- 0.87%的渗透性(r(2 )= 0.994)。透射电子显微镜显示在凝胶基质中截留的球形聚合物胶束。一系列测试显示了水合能力,无刺激性和具有适当处理特性的组织学上安全的凝胶配方。最终,已成功开发出能够通过局部递送将药物携带到眼前段的控释pH敏感性眼用制剂,用于治疗真菌性角膜炎。 (C)2015由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号